The medicinal chemist has demonstrated remarkable prowess in furnishing dual inhibitory antitumor chemical architectures. Scaffold hopping-based drug design strategies have yielded a plethora of pharmacodynamically superior dual modulatory antitumor agents.

#scaffoldhopping #drugdiscovery

1/5

Success is achieved not by mere desire, but by the relentless pursuit of small, actionable steps towards the goal.

FDA approves first cell therapy for type 1 diabetes.

Source: https://www.nature.com/articles/d41573-023-00113-w